What Cannabis Industry Topics Does MJBizDaily Cover Most Often?

MJBizDaily focuses on the business, legal, and regulatory side of the legal cannabis industry rather than consumer or lifestyle content. Based on its current front page, its coverage clusters around four recurring topics: regulation and enforcement, corporate deals and capital, tax and legal risk, and state-level market and product-safety news. If your interest is licensing rules, M&A, tax exposure, or state market shifts, the publication is likely relevant; if you want product reviews or consumer guides, it is not the right fit.

Regulation and enforcement

This is the most frequent category on the page. Recent examples include:

• New York payment enforcement: The state now requires suppliers to report unpaid net-30 invoices within seven days. MJBizDaily frames the retail impact directly—retailers say smaller orders mean lost discounts.
• New Jersey unlicensed sellers: A bipartisan bill would fine unlicensed cannabis retailers $10,000 to $250,000 and shut down repeat offenders.
• Federal rescheduling compliance: A legal opinion suggests states do not need to change their rules to comply with federal marijuana rescheduling, using South Dakota's medical program as the example.

The pattern is consistent: a rule or bill changes, and the coverage explains who it hits and how operators are adjusting.

Corporate deals and capital

MJBizDaily tracks takeover bids and investment shifts as they happen. The Curaleaf–Aurora story is a clear case: Aurora's board rejected Curaleaf's enhanced takeover bid without talks, and Curaleaf pushed back, saying the offer carried a 217% premium when cash is excluded. Aurora also signaled openness to bids from other companies.

Related coverage connects rescheduling to capital flows—one piece argues federal rescheduling means institutional capital is coming to cannabis investing, and another says integration, not just deal volume, decides who wins as rescheduling fuels deals.

Tax and legal risk

Tax exposure gets steady attention, often beyond headline policy:

• 280E and audits: A featured piece looks at hidden tax audit risks of marijuana rescheduling beyond 280E relief.
• Criminal tax charges: The CEO of an Oregon-based vertically integrated multistate operator was charged with federal tax fraud.
• Rescheduling mechanics: Coverage explains how federal rescheduling affects state compliance and deal structures.

State markets and product safety

State-level developments appear daily:

• Massachusetts: The latest poll shows an adult-use sales repeal failing badly—no issue unites voters like keeping sales legal.
• Colorado: A cannabis vape recall expanded as health complaints rose, with three health and safety notices since Sept. 25 pulling Craft THC vapes from more than 700 retailers.
• Nebraska: Medical marijuana growers harvested their first crops with no processors, transporters, labs, or dispensaries to receive them.
• New York market entry: A founder's warning about entering the cannabis industry in 2026—"Don't do it"—reflects the publication's willingness to run skeptical operator voices.

What this means for your reading

One caveat: the page also carries sponsored content, such as a piece on agentic AI for cannabis operators, which is labeled as sponsored and should be read as marketing rather than editorial reporting.